|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:618-619
© 1999 Mosby, Inc.
BRIEF COMMUNICATIONS |
From the Division of Surgery,a Toneyama National Hospital, and Division of Surgery,b Kinki Central National Hospital for Chest Diseases, Osaka, Japan.
Received for publication Aug 19, 1998. Accepted for publication Oct 14, 1998. Address for reprints: Noriyoshi Sawabata, MD, Division of Surgery, Toneyama National Hospital, 5-1-1 Toneyama, Toyonaka, Osaka, Japan 560-8552.
Tumor excision is a strategy to treat peripheral pulmonary malignant lesions in high-risk candidates for lobectomy or pneumonectomy and in patients with metastatic tumors.
1-3 Certain wedge-excised malignant tumors recur at the surgical margin despite histologic evidence of a safe margin.
4 Even if the histologic examination reveals no evidence of malignancy on the margin of an excised tumor, this is no guarantee that the lung tissue around the excised margin is free from malignant cells, because histologic examination cannot study all aspects of the surgical margin of an excised tumor. Besides, cytologically, we can collect specimens from the whole area of the surgical margin of an excised malignant tumor. The purpose of this study is to demonstrate the method and the early results of cytologic examination on the surgical margins of wedge-excised tumors.
Technique
From April 1996 to May 1998, 35 small peripheral malignant pulmonary nodules (less than 3 cm in diameter) from 30 patients were excised. The patients, aged 50 to 82 years, included 24 men and 6 women. Seven lesions were subjected to video-assisted thoracoscopic surgery (VATS) and 28 to thoracotomy. Preoperative diagnoses were as follows: 8 undiagnosed lung cancers, 17 lung cancers, and 10 metastatic cancers from colorectal carcinoma.
Cytologic examination of the surgical margin was performed before the cross section was studied to prevent malignant cell contamination. Material for cytologic examination of the surgical margin of wedge-excised lung was harvested with a glass slide. The glass side was run across the staple site at least three times until sufficient material was collected. The harvested sample was spread on another glass slide and fixed by ethanol spray as soon as possible. It took approximately 15 seconds to harvest samples for cytologic examination and 12 minutes to apply the Papanicolaou stain. A cytopathologist was on site and interpreted the slide. After the materials for cytologic examination had been harvested, the wedge-resected specimen was cut and examined grossly and pathologically. Cytologic diagnoses of surgical margins of wedge-resected malignant tumors are described in Fig. 1. Among 15 samples showing histologically safe marginal distance (more than 10 mm), 40% (6/15) had cytologically positive margins.
|
|
It has been reported that approximately 30% of excised solitary malignant pulmonary tumors recur on the surgical margin.
1-3 Therefore it is important to identify whether a malignant tumor has been resected completely. We assume that a malignant tumor has been resected with a safe margin when frozen section shows no evidence of malignancy. However, excised malignant tumors have recurred on the surgical margin despite histologically clean surgical margins.
4 With cytologic examination, it is possible to harvest materials from the whole surgical margin. Therefore cytologic examination is also considered an effective means of detecting malignant cell contamination. In this study, 40% (6/15) of samples with histologically safe surgical margins (more than 10 mm) had cytologically positive surgical margins. In certain of these cases, malignant tumor recurred on these margins despite the clean histologic results.
A recent publication from the Canadian Lung Oncology Group
5 maintained that margins of resection, whether histologically positive or negative, do not affect 3-year survival or 3-year recurrence rate. The recurrence rates described in this report were 40% (10/25) in patients with positive surgical margins and 49% (184/374) in those with negative margins. However, inasmuch as the authors did not mention local recurrence, we cannot determine the local recurrence rate from their article. Moreover, they examined the surgical margins histologically. Had they used cytologic methods, it is likely that cytologically positive margins would have been discovered in patients with histologically negative margins. Tumor recurring on the surgical margin would be treated again in most cases. It would be significant if an improved disease-free interval could be demonstrated with this technique. If this method could predict local recurrence, it would be a guideline for adjuvant therapy.
In conclusion, cytologic examination of the surgical margins of wedge-resected malignant tumors was also useful to detect malignant cell contamination.
References
This article has been cited by other articles:
![]() |
N. Sawabata, Y. Karube, H. Umezu, M. Tamura, N. Seki, H. Ishihama, K. Honma, and S. Miyoshi Cytologically malignant margin without continuous pulmonary tumor lesion: cases of wedge resection, segmentectomy and lobectomy Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1044 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata A segmentectomy for stage IA non small cell lung cancer should be associated with surgical margin cytology findings and a frozen section histologic examination of lymph nodes J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 822 - 822. [Full Text] [PDF] |
||||
![]() |
A. Orki, C. Tezel, A. Kosar, A. A. Ersev, C. Dudu, and B. Arman Feasibility of Imprint Cytology for Evaluation of Mediastinal Lymph Nodes in Lung Cancer Jpn. J. Clin. Oncol., February 1, 2006; 36(2): 76 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shiono, G. Ishii, K. Nagai, J. Yoshida, M. Nishimura, Y. Murata, K. Tsuta, Y. H. Kim, Y. Nishiwaki, T. Kodama, et al. Predictive Factors for Local Recurrence of Resected Colorectal Lung Metastases Ann. Thorac. Surg., September 1, 2005; 80(3): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Inoue, S.-i. Takeda, and H. Maeda Limited resection of non-small cell lung cancer: should brachytherapy be indicated in all cases? Ann. Thorac. Surg., April 1, 2004; 77(4): 1503 - 1504. [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Ohta, A. Matsumura, K. Nakagawa, H. Hirano, H. Maeda, and H. Matsuda Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study Ann. Thorac. Surg., February 1, 2004; 77(2): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata Malignant status at surgical margin of limited-resected non-small cell lung cancer: a crucial finding for predicting local relapse J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 610 - 611. [Full Text] [PDF] |
||||
![]() |
M. Higashiyama, K. Kodama, K. Takami, N. Higaki, T. Nakayama, and H. Yokouchi Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 101 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, A. Matsumura, M. Ohota, H. Maeda, H. Hirano, K. Nakagawa, and H. Matsuda Cytologically malignant margins of wedge resected stage I non-small cell lung cancer Ann. Thorac. Surg., December 1, 2002; 74(6): 1953 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, H. Maeda, M. Ohta, and M. Hayakawa Operable Non-small Cell Lung Cancer Diagnosed by Transpleural Techniques : Do They Affect Relapse and Prognosis? Chest, November 1, 2001; 120(5): 1595 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sawabata, M. Ohta, and H. Maeda Fine-Needle Aspiration Cytologic Technique for Lung Cancer Has a High Potential of Malignant Cell Spread Through the Tract Chest, October 1, 2000; 118(4): 936 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Higashiyama, K. Kodama, H. Yokouchi, K. Takami, T. Nakayama, and T. Horai A novel test of the surgical margin in patients with lung cancer undergoing limited surgery: Lavage cytologic technique J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 412 - 413. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |